The Atypical Protein Kinase C Small Molecule Inhibitor ζ-Stat, and Its Effects on Invasion Through Decreases in PKC-ζ Protein Expression

Ovarian cancer is estimated to reach 22,530 diagnoses and cause 13,980 cancer deaths per year. The most common histology diagnosed of ovarian cancer is epithelial ovarian carcinomas (EOC). An aggressive epithelial subtype is clear cell ovarian carcinoma (CCOC) and is characterized as a non-serous ov...

Full description

Bibliographic Details
Main Authors: Tracess Smalley, Rainer Metcalf, Rekha Patel, S. M. Anisul Islam, Raja Reddy Bommareddy, Mildred Acevedo-Duncan
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00209/full
_version_ 1819146327601184768
author Tracess Smalley
Rainer Metcalf
Rekha Patel
S. M. Anisul Islam
Raja Reddy Bommareddy
Mildred Acevedo-Duncan
author_facet Tracess Smalley
Rainer Metcalf
Rekha Patel
S. M. Anisul Islam
Raja Reddy Bommareddy
Mildred Acevedo-Duncan
author_sort Tracess Smalley
collection DOAJ
description Ovarian cancer is estimated to reach 22,530 diagnoses and cause 13,980 cancer deaths per year. The most common histology diagnosed of ovarian cancer is epithelial ovarian carcinomas (EOC). An aggressive epithelial subtype is clear cell ovarian carcinoma (CCOC) and is characterized as a non-serous ovarian cancer. Protein kinase C (PKC) is an enzymatic family of proteins that have been found to be a component in cancer progression, tissue invasion, and metastasis. The atypical PKC (aPKC) isoforms, PKC-ι and PKC-ζ, have been suggested to participate in the increased proliferation of ovarian cancers. Previous studies have indicated that novel aPKC inhibitors ICA-1S and ζ-Stat decreased the migratory behaviors of colorectal cancer cells and were selective for PKC-ι/λ and PKC-ζ, respectively. The aims of this investigation were to further determine the binding mechanisms of ζ-Stat, expand on the tissue range of these compounds, investigate the therapeutic potential of ζ-Stat in CCOC, and to illustrate the disruption of invasion via the PKC-ζ signaling cascade. The methods utilized were molecular docking and virtual target screening, Western blot analysis, end-point PCR, GST pull down, cell viability and invasion and migration assays. We discovered that the small molecule inhibitor, ζ-Stat, is a prospective drug candidate to investigate as a novel potential treatment for CCOC. We also found that the PKC-ζ/Ect2/Rac1 activation pathway was decreased by ζ-Stat, which in turn decreased invasive behavior of CCOC.
first_indexed 2024-12-22T13:12:10Z
format Article
id doaj.art-3a64076844554605af749deabd02eada
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-22T13:12:10Z
publishDate 2020-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-3a64076844554605af749deabd02eada2022-12-21T18:24:43ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-02-011010.3389/fonc.2020.00209487702The Atypical Protein Kinase C Small Molecule Inhibitor ζ-Stat, and Its Effects on Invasion Through Decreases in PKC-ζ Protein ExpressionTracess SmalleyRainer MetcalfRekha PatelS. M. Anisul IslamRaja Reddy BommareddyMildred Acevedo-DuncanOvarian cancer is estimated to reach 22,530 diagnoses and cause 13,980 cancer deaths per year. The most common histology diagnosed of ovarian cancer is epithelial ovarian carcinomas (EOC). An aggressive epithelial subtype is clear cell ovarian carcinoma (CCOC) and is characterized as a non-serous ovarian cancer. Protein kinase C (PKC) is an enzymatic family of proteins that have been found to be a component in cancer progression, tissue invasion, and metastasis. The atypical PKC (aPKC) isoforms, PKC-ι and PKC-ζ, have been suggested to participate in the increased proliferation of ovarian cancers. Previous studies have indicated that novel aPKC inhibitors ICA-1S and ζ-Stat decreased the migratory behaviors of colorectal cancer cells and were selective for PKC-ι/λ and PKC-ζ, respectively. The aims of this investigation were to further determine the binding mechanisms of ζ-Stat, expand on the tissue range of these compounds, investigate the therapeutic potential of ζ-Stat in CCOC, and to illustrate the disruption of invasion via the PKC-ζ signaling cascade. The methods utilized were molecular docking and virtual target screening, Western blot analysis, end-point PCR, GST pull down, cell viability and invasion and migration assays. We discovered that the small molecule inhibitor, ζ-Stat, is a prospective drug candidate to investigate as a novel potential treatment for CCOC. We also found that the PKC-ζ/Ect2/Rac1 activation pathway was decreased by ζ-Stat, which in turn decreased invasive behavior of CCOC.https://www.frontiersin.org/article/10.3389/fonc.2020.00209/fullPKC-ζPKC-zetaEct2clear cell ovarian carcinoma (CCOC)ζ-Statzeta-Stat
spellingShingle Tracess Smalley
Rainer Metcalf
Rekha Patel
S. M. Anisul Islam
Raja Reddy Bommareddy
Mildred Acevedo-Duncan
The Atypical Protein Kinase C Small Molecule Inhibitor ζ-Stat, and Its Effects on Invasion Through Decreases in PKC-ζ Protein Expression
Frontiers in Oncology
PKC-ζ
PKC-zeta
Ect2
clear cell ovarian carcinoma (CCOC)
ζ-Stat
zeta-Stat
title The Atypical Protein Kinase C Small Molecule Inhibitor ζ-Stat, and Its Effects on Invasion Through Decreases in PKC-ζ Protein Expression
title_full The Atypical Protein Kinase C Small Molecule Inhibitor ζ-Stat, and Its Effects on Invasion Through Decreases in PKC-ζ Protein Expression
title_fullStr The Atypical Protein Kinase C Small Molecule Inhibitor ζ-Stat, and Its Effects on Invasion Through Decreases in PKC-ζ Protein Expression
title_full_unstemmed The Atypical Protein Kinase C Small Molecule Inhibitor ζ-Stat, and Its Effects on Invasion Through Decreases in PKC-ζ Protein Expression
title_short The Atypical Protein Kinase C Small Molecule Inhibitor ζ-Stat, and Its Effects on Invasion Through Decreases in PKC-ζ Protein Expression
title_sort atypical protein kinase c small molecule inhibitor ζ stat and its effects on invasion through decreases in pkc ζ protein expression
topic PKC-ζ
PKC-zeta
Ect2
clear cell ovarian carcinoma (CCOC)
ζ-Stat
zeta-Stat
url https://www.frontiersin.org/article/10.3389/fonc.2020.00209/full
work_keys_str_mv AT tracesssmalley theatypicalproteinkinasecsmallmoleculeinhibitorzstatanditseffectsoninvasionthroughdecreasesinpkczproteinexpression
AT rainermetcalf theatypicalproteinkinasecsmallmoleculeinhibitorzstatanditseffectsoninvasionthroughdecreasesinpkczproteinexpression
AT rekhapatel theatypicalproteinkinasecsmallmoleculeinhibitorzstatanditseffectsoninvasionthroughdecreasesinpkczproteinexpression
AT smanisulislam theatypicalproteinkinasecsmallmoleculeinhibitorzstatanditseffectsoninvasionthroughdecreasesinpkczproteinexpression
AT rajareddybommareddy theatypicalproteinkinasecsmallmoleculeinhibitorzstatanditseffectsoninvasionthroughdecreasesinpkczproteinexpression
AT mildredacevedoduncan theatypicalproteinkinasecsmallmoleculeinhibitorzstatanditseffectsoninvasionthroughdecreasesinpkczproteinexpression
AT tracesssmalley atypicalproteinkinasecsmallmoleculeinhibitorzstatanditseffectsoninvasionthroughdecreasesinpkczproteinexpression
AT rainermetcalf atypicalproteinkinasecsmallmoleculeinhibitorzstatanditseffectsoninvasionthroughdecreasesinpkczproteinexpression
AT rekhapatel atypicalproteinkinasecsmallmoleculeinhibitorzstatanditseffectsoninvasionthroughdecreasesinpkczproteinexpression
AT smanisulislam atypicalproteinkinasecsmallmoleculeinhibitorzstatanditseffectsoninvasionthroughdecreasesinpkczproteinexpression
AT rajareddybommareddy atypicalproteinkinasecsmallmoleculeinhibitorzstatanditseffectsoninvasionthroughdecreasesinpkczproteinexpression
AT mildredacevedoduncan atypicalproteinkinasecsmallmoleculeinhibitorzstatanditseffectsoninvasionthroughdecreasesinpkczproteinexpression